A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

Updated 06/21/2024

Status Completed

Clinical Trial Summary

A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01401985
Study type	Interventional
Source	Theravance Biopharma
Contact
Status	Completed
Phase	Phase 2
Start date	October 2011
Completion date	August 2012

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT02813369` - Naloxegol Health Outcome Post Authorisation Safety Study
	Completed	`NCT01957046` - A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).	Phase 4
	Completed	`NCT00984334` - Naloxone SR Capsules in Patients With Opioid Induced Constipation	Phase 2
	Completed	`NCT01207427` - Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain	Phase 2
	Completed	`NCT01459926` - A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation	Phase 2
	Terminated	`NCT01117051` - Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation	Phase 3
	Completed	`NCT03060512` - To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation	Phase 4
	Completed	`NCT01109511` - A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy	Phase 4
	Active, not recruiting	`NCT02813356` - Naloxegol US PMR CV Safety.
	Completed	`NCT01812733` - Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives	N/A
	Completed	`NCT01623609` - Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol	Phase 1
	Completed	`NCT02813148` - Naloxegol Drug Utilization Post Authorisation Safety Study
	Completed	`NCT01443403` - A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy	Phase 2
	Completed	`NCT03638440` - Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.